Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Vaccines
Recent news which mentions Vaccines
< Previous
1
2
Next >
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
January 08, 2025
Tickers
CVAC
FTXH
GSK
IDNA
Tags
Sector ETFs
Biotech ETF
MRNA
From
Benzinga
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 07, 2025
Tickers
EVS
IONQ
MRNA
NEWS
Tags
IONQ
Shivdeep Dhaliwal
Jensen Huang
From
Benzinga
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
December 13, 2024
Tickers
GSK
MRNA
PFE
Tags
MRNA
Vaccines
bird flu
From
Benzinga
Bird Flu Found In Raw Milk Leads To Recall In California
November 26, 2024
Tickers
GSK
MRNA
NEWS
SNY
Tags
Market News
Health Care
Movers
From
Benzinga
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
November 20, 2024
Tickers
GSK
MRNA
NEWS
PFE
Tags
SNY
Health Care
Market News
From
Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
Tickers
BNTX
CDC
GSK
MRNA
Tags
Benzinga
Government
GSK
From
Benzinga
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
August 26, 2024
Tickers
BVNRY
EBS
GOVX
NEWS
Tags
Stories That Matter
Benzinga
Tedros Adhanom Ghebreyesus
From
Benzinga
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency
August 16, 2024
Tickers
BVNKF
BVNRY
NEWS
Tags
Biotech
Government
why it's moving
From
Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
Tickers
BVNRY
CDC
EBS
GOVX
Tags
Stories That Matter
WHO
Benzinga
From
Benzinga
AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding
August 14, 2024
Tickers
AZN
NEWS
Tags
AZN
Briefs
Vaccines
From
Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Tickers
CVAC
MRNA
NEWS
NVAX
Tags
Regulations
Markets
Vaccines
From
Benzinga
Healthcare Champions Kick Off 2024
January 05, 2024
Tickers
MRK
MRNA
NEWS
WBA
Tags
Markets
MRK
Vaccines
From
Benzinga
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
Tickers
MRK
MRNA
Tags
MRK
Markets
Benzinga
From
Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
Tickers
MRK
MRNA
MYNZ
PFE
Tags
Benzinga
Biotech
MYNZ
From
Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
Tickers
BNTX
MRNA
NVAX
PFE
Tags
2024 election
Politics
Ron DeSantis
From
Benzinga
Gavi's 6-In-1 Vaccine May Prove Game-Changer For Polio Eradication: STAT News
June 23, 2023
Tags
Biotech
Benzinga
Polio
From
Benzinga
FDA Votes In Favor Of Pfizer's Maternal RSV Vaccine To Prevent Disease In Infants
May 19, 2023
Tickers
PFE
Tags
Top Stories
News
PFE
From
Benzinga
Bill Gates Says Providing nOPV2-Like Vaccines To 'Zero-Dose' Children Will Usher In 'Healthier Future For Us All'
April 29, 2023
Tags
Polio
General
News
From
Benzinga
NFL's Aaron Rodgers' Hail Mary For 2024 Presidential Election: Fellow Anti-Vaxxer Robert Kennedy Jr.
April 13, 2023
Tickers
SQ
Tags
Markets
Aaron Rodgers
CBDCs
From
Benzinga
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
March 01, 2023
Tickers
EBS
JNJ
MRNA
NVAX
Tags
Biotech
Benzinga
NVAX
From
Benzinga
EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch
December 15, 2022
Tickers
ICVX
MULN
NFLX
PFE
Tags
Trading Ideas
Stocks To Watch
SOFI
From
Benzinga
US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data — Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today
October 13, 2022
Tickers
AMAT
DWAC
QQQ
SPY
Tags
Market News
Economics
Nasdaq futures
From
Benzinga
Monkeypox vaccines: A virologist answers 6 questions about how they work, who can get them and how well they prevent infection
August 05, 2022
Tags
science
Sciences & Technology
Monkeypox
From
Phil's Stock World
Former Disney Employees Sue Over Vaccine, Mask Rules
July 12, 2022
Tickers
DIS
Tags
Benzinga
Legal
religious freedom
From
Benzinga
J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement
June 07, 2022
Tickers
EBS
JNJ
Tags
Biotech
Benzinga
Vaccines
From
Benzinga
Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment
June 07, 2022
Tickers
BNTX
PFE
Tags
Market News
Vaccines
News
From
Benzinga
EXCLUSIVE: Tonix CEO Seth Lederman On The Pursuit Of New Monkeypox, COVID Vaccines
June 01, 2022
Tickers
TNXP
Tags
Interview
Health Care
Market News
From
Benzinga
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
May 10, 2022
Tickers
BNTX
MRNA
NVAX
PFE
Tags
News
Top Stories
General
From
Benzinga
Pfizer Could Seek COVID-19 Vaccine Emergency Approval For Children Under 5 This Week
January 31, 2022
Tickers
BNTX
PFE
Tags
Vaccines
Market News
Pandemic
From
Benzinga
Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine
January 20, 2022
Tickers
MRNA
NVAX
PFE
Tags
Covid/19
Market News
Pandemic
From
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.